PureTech Health PLC (PRTC) ニュース

PureTech Health: Result of General Meeting

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company

Akili to operate as wholly owned subsidiary of Virtual Therapeutics PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company...

PureTech to Present at the Jefferies Global Healthcare Conference

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics...

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection

VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC TO-I - Tender offer statement by Issuer

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

Notice of General Meeting PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company...

PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

SPT-300 demonstrated nine times greater allopregnanolone exposure in humans dosed orally than published data for oral allopregnanolone,1...

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare executive at...

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1...

PureTech Health: Notice of Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results...